Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$2.85 USD
+0.06 (2.26%)
Updated Sep 9, 2024 03:58 PM ET
After-Market: $2.87 +0.03 (0.88%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.85 USD
+0.06 (2.26%)
Updated Sep 9, 2024 03:58 PM ET
After-Market: $2.87 +0.03 (0.88%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Zacks News
Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y
by Zacks Equity Research
Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.
Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -38.58% and 37.47%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Hydrofarm Holdings Group, Inc. (HYFM) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Hydrofarm (HYFM) delivered earnings and revenue surprises of -21.74% and 3.38%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
by Zacks Equity Research
Arcadia Biosciences (RKDA) sells its GoodWheat brand to scale up its wheat IP.
Arcadia Biosciences (RKDA) Shares Gain on Q1 Earnings Beat
by Zacks Equity Research
Arcadia Biosciences' (RKDA) Q1 results benefit from a decline in operating expenses.
Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 29.37% and 4.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 22nd
by Zacks Equity Research
AMN, PRG and RKDA have been added to the Zacks Rank #5 (Strong Sell) List on April 22, 2024.
Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y
by Zacks Equity Research
Arcadia Biosciences (RKDA) reports improved top-line results in the fourth quarter of 2023, which is aided by higher GoodWheat and GLA revenues.
Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 7.46% and 35%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights like West Fraser Timber, CalMaine Foods, GrowGeneration, Hydrofarm and Arcadia Biosciences
by Zacks Equity Research
West Fraser Timber, CalMaine Foods, GrowGeneration, Hydrofarm and Arcadia Biosciences are part of the Zacks Industry Outlook article.
5 Agriculture - Products Stocks to Watch in a Challenging Industry
by Madhurima Das
The Zacks Rank for the Agriculture - Products industry paints a gloomy picture. Investors should keep an eye on these five stocks braving the industry headwinds -- West Fraser (WFG), CalMaine Foods (CALM), GrowGeneration (GRWG), Hydrofarm (HYFM) and Arcadia Biosciences (RKDA).
Zacks Industry Outlook Highlights Bunge, The Andersons and Arcadia Biosciences
by Zacks Equity Research
Bunge, The Andersons and Arcadia Biosciences have been highlighted in this Industry Outlook article.
3 Agriculture - Products Stocks to Watch in a Promising Industry
by Madhurima Das
The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), Andersons (ANDE) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
GrowGeneration (GRWG) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
GrowGeneration (GRWG) delivered earnings and revenue surprises of -9.09% and 1.29%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for October 25th
by Zacks Equity Research
RKDA, GHRS, GPS, RITM and EXAI have been added to the Zacks Rank #1 (Strong Buy) List on October 25, 2023.
New Strong Buy Stocks for October 17th
by Zacks Equity Research
MNTX, PGNY, GFF, RKDA and CYCC have been added to the Zacks Rank #1 (Strong Buy) List on October 17, 2023.
3 Stocks to Watch in the Thriving Agriculture - Products Industry
by Madhurima Das
The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), Andersons (ANDE) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
Arcadia Biosciences (RKDA) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 46.34% and 2.87%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Orion (OEC) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Orion (OEC) delivered earnings and revenue surprises of -10.17% and 16.30%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
GrowGeneration (GRWG) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
GrowGeneration (GRWG) delivered earnings and revenue surprises of -28.57% and 0.15%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks With Rising P/E to Bet on for Solid Gains
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include Crocs (CROX), AlloVir (ALVR), Arcadia Biosciences (RKDA), The Duckhorn Portfolio (NAPA) and Genuine Parts (GPC).
Westlake Chemical (WLK) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Westlake (WLK) delivered earnings and revenue surprises of -18.37% and 5.73%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Intrepid Potash (IPI) Q2 Earnings Lag Estimates
by Zacks Equity Research
Intrepid Potash (IPI) delivered earnings and revenue surprises of -26.67% and 21.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?